ArticleNeuropsychiatric disease and treatment2018

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials.

Taro Kishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.